| Cytochrome P450 2D6 and Parkinson’s disease: polymorphism, metabolic role, risk and protection MSU Rasheed, AK Mishra, MP Singh Neurochemical Research 42 (12), 3353-3361, 2017 | 39 | 2017 |
| Resveratrol protects from toxin-induced Parkinsonism: plethora of proofs hitherto petty translational value MSU Rasheed, MK Tripathi, AK Mishra, S Shukla, MP Singh Molecular Neurobiology 53 (5), 2751-2760, 2016 | 37 | 2016 |
| Cypermethrin activates autophagosome formation albeit inhibits autophagy owing to poor lysosome quality: relevance to Parkinson’s disease AK Mishra, S Mishra, C Rajput, MSU Rasheed, DK Patel, MP Singh Neurotoxicity research 33 (2), 377-387, 2018 | 30 | 2018 |
| Aberrant autophagy and Parkinsonism: does correction rescue from disease progression? AK Mishra, MSU Rasheed, S Shukla, MK Tripathi, A Dixit, MP Singh Molecular Neurobiology 51 (3), 893-908, 2015 | 28 | 2015 |
| Silymarin protects against impaired autophagy associated with 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced Parkinsonism MK Tripathi, MSU Rasheed, AK Mishra, DK Patel, MP Singh Journal of Molecular Neuroscience 70, 276-283, 2020 | 24 | 2020 |
| Resveratrol regulates Nrf2-mediated expression of antioxidant and xenobiotic metabolizing enzymes in pesticides-induced parkinsonism MSU Rasheed, MK Tripathi, DK Patel, MP Singh Protein and Peptide Letters 27 (10), 1038-1045, 2020 | 21 | 2020 |
| Malfunctioning of chaperone-mediated autophagy in Parkinson’s disease: Feats, Constraints, and Flaws of modulators MK Tripathi, C Rajput, MSU Rasheed, S Mishra, MP Singh Neurotoxicity Research 35 (1), 260-270, 2019 | 20 | 2019 |
| Redox modulation of mitochondrial proteins in the neurotoxicant models of Parkinson's disease A Sarkar, MSU Rasheed, MP Singh Antioxidants & Redox Signaling 38 (10-12), 824-852, 2023 | 6 | 2023 |
| Coherent and contradictory facts, feats and fictions associated with metal accumulation in Parkinson’s disease: epicenter or outcome, yet a demigod question MSU Rasheed, S Tripathi, S Mishra, MP Singh Molecular Neurobiology 54 (6), 4738-4755, 2017 | 6 | 2017 |
| Opioid-sparing effects of the Nrf2 activator diroximel fumarate in mice MSU Rasheed, FR Cherry, PM Grace The Journal of Pain 23 (5), 60-61, 2022 | 2 | 2022 |
| Site-specific drug release of monomethyl fumarate to treat oxidative stress disorders TD Avery, J Li, DJL Turner, MSU Rasheed, FR Cherry, DL Stachura, ... Nature biotechnology, 1-4, 2024 | 1 | 2024 |
| Systemic and targeted activation of Nrf2 reverses doxorubicin-induced cognitive impairments and sensorimotor deficits in mice AK Singh, D Ruiz, MSU Rasheed, TD Avery, DJL Turner, AD Abell, ... bioRxiv, 2024 | 1 | 2024 |
| Drug targeting to sites of oxidative stress using the Baeyer-Villiger reaction TD Avery, J Li, DJL Turner, FR Cherry, MS Ur Rasheed, C Aguilar, ... bioRxiv, 2021.09. 03.458872, 2021 | 1 | 2021 |
| Pathology activated prodrugs targeting Nrf2 to treat neuropathic pain J Li, TD Avery, DJL Turner, FR Cherry, MSU Rasheed, C Aguilar, ... The Journal of Pain 23 (5), 2, 2022 | | 2022 |
| The Role of Nuclear Factor Erythroid 2-Related Factor 2 (NRF2) in Preventing Inflammasome Activation in Peripheral Nerve Injury F Cherry, MSU Rasheed, MV Chavez, J Li, PM Grace The Journal of Pain 23 (5), 14-15, 2022 | | 2022 |
| Resveratrol restores CYP2D6 enzyme activity and upregulates NRF2-keap1 pathway in maneb-and paraquat-treated SH-SY5Y cell line MS Rasheed, MP Singh JOURNAL OF NEUROCHEMISTRY 142, 110-110, 2017 | | 2017 |
| EGFR inhibitors when used in conjunction with anti-PD-1 mAb could increase the efficacy of immunotherapy in lung adenocarcinomas. Menu AT Shaw, BJ Solomon, R Chiari, GJ Riely, B Besse, RA Soo, S Kao, ... | | |